Connect with us

Technology

Gene Solutions Advances Precision Oncology Education in Malaysia with the ”Beyond Actionable” Academy

Published

2 months ago

on

At the Precision Oncology Academy 2026, leading international experts explored how insights from tumour DNA and RNA can reveal treatment opportunities, explain drug resistance, and translate into more confident treatment decisions to improve cancer care.

KUALA LUMPUR, Malaysia, Aug. 4, 2026 /PRNewswire/ — Gene Solutions Malaysia hosted the Precision Oncology Academy 2026 on 25 July 2026 at the Sheraton Petaling Jaya Hotel under the theme ”Beyond Actionable”. An extension of the international K-CONNECT Platform and the recent K-CONNECT Summit 2026 in Vietnam, the Academy brought together oncology experts from the United Arab Emirates, Singapore, Malaysia, US and Vietnam. Through scientific lectures, multidisciplinary case discussions and interactive workshops, the programme addressed a central question: How can a deeper understanding of each patient’s cancer lead to more informed treatment decisions?

The Academy’s expert faculty was led by Chairperson Prof. Dr. Ho Gwo Fuang of Curie Oncology, Malaysia, and Co-chairperson Prof. Dr. Darren Lim Wan-Teck of the National Cancer Centre Singapore. They were joined by Prof. Dr. Shaheenah Dawood of Mediclinic Middle East, UAE; Dr. Christina Lai Nye Bing of Hospital Picaso, Malaysia; Dr. Katherine Teh Hooi Lay of Gleneagles Hospital Johor, Malaysia; Dr. Jenson Sow Wen Jen of Curie Oncology, Malaysia; Dr. Sinh Nguyen Duy and Dr. Lan Tu Ngoc Ly of Gene Solutions. Together, the faculty brought expertise spanning clinical oncology, cancer genomics, molecular diagnostics and genomic data interpretation, creating a multidisciplinary forum for translating complex molecular insights into practical clinical decisions.

Decoding the molecular story of cancer

Cancer is not defined solely by its site of origin in the body. Every tumour carries a complex molecular story, written in changes across its DNA and RNA. These changes influence how cancer develops, how it responds to treatment and how it may become resistant over time.

The Academy examined how large genomic and transcriptomic panels comprehensive profiling can provide a broader view of tumour biology. This includes comprehensive multi-omic approaches such as K-4CARE, which combines tissue-based DNA and RNA profiling with liquid biopsy circulating tumour DNA (ctDNA) analysis for both molecular profiling and ongoing monitoring. DNA profiling may identify genomic alterations associated with cancer growth and reveal biomarkers linked to targeted therapies, immunotherapies or clinical trials. RNA analysis can detect clinically important gene fusions and splice variants that may be missed or remain unclear through DNA-only testing.

The discussions highlighted the complementary roles of tissue and liquid (plasma) next-generation sequencing. While tissue testing remains essential for initial diagnosis and detailed characterisation, liquid biopsy can capture a wider view of tumour heterogeneity and resistance, particularly at progression. Used together, the two approaches offer clinicians a more complete molecular picture to guide treatment decisions.

The value of tissue and liquid longitudinal molecular profiling was illustrated by Prof. Dr. Darren Lim, who presented a real-world case of a patient with ALK-positive lung cancer managed over several years with serial next-generation sequencing. The case illustrated how repeated molecular profiling — combining tissue and plasma testing — can reveal a broader resistance landscape and support sequential treatment decisions throughout a patient’s journey.

Together, DNA, RNA, and ctDNA insights can provide clinicians with a more comprehensive understanding of the tumour. Molecular testing does not guarantee an actionable finding or suitable treatment, but it may uncover important information that would otherwise remain unseen.

Following cancer as it evolves

The Academy also highlighted the growing role of liquid biopsy in providing a more dynamic and holistic view of cancer.

One of the Academy’s key international speakers, Prof. Dr. Shaheenah Dawood, shared clinical perspectives on the evolving role of minimal residual disease (MRD) and ctDNA monitoring across cancer types. Prof. Dr. Dawood also reviewed the latest ASCO and NCCN guideline updates on liquid biopsy.

While tissue biopsy examines tumour material obtained from a particular location at a particular point in time, liquid biopsy detects cancer-related signals, including ctDNA, in the blood and can be repeated with a single blood draw. Depending on the clinical context and available evidence, liquid biopsy may help clinicians monitor treatment response, investigate emerging resistance or detect molecular signs of MRD. Because it can be performed repeatedly over time, liquid biopsy also offers the potential to follow how a cancer changes throughout treatment.

“The future of cancer management is dynamic. Liquid biopsy enables continuous monitoring of tumour evolution, helping clinicians make earlier, more informed treatment decisions.” said Prof. Shaheenah Dawood.

From complex data to confident decisions

The speakers emphasized that precision oncology is not simply about testing more genes or generating more data. The real challenge is determining which findings are clinically meaningful for an individual patient.

Not every molecular alteration drives cancer, and not every detected alteration can guide treatment. When a potentially actionable biomarker is identified, clinicians must consider the strength of the supporting evidence, the cancer type, previous treatments, the patient’s overall condition, and the availability of appropriate therapies or clinical trials.

This is why genomic findings must be interpreted together with pathology, medical history, and multidisciplinary clinical expertise.

“Precision oncology is no longer just about generating genomic data. It is about translating genomic insights, including MRD and ctDNA, into confident clinical decisions that improve patient care.” said Prof. Ho Gwo Fuang who chaired the Academy.

Connecting regional knowledge with clinical practice

The Precision Oncology Academy followed the K-CONNECT Summit 2026 | AI & Multi-omics – Shifting Paradigms in the New Era of Early Cancer Detection and Precision Oncology, recently held in Vietnam.

K-CONNECT was established by Gene Solutions as an international platform for multidisciplinary exchange in cancer genomics, ctDNA, molecular residual disease monitoring, comprehensive genomic and transcriptomic profiling, artificial intelligence and precision medicine.

“The K-CONNECT Platform was created to foster collaboration across the region, while Precision Oncology Academy translates that collaboration into practical clinical learning. By bringing together leading experts and real-world evidence, we hope to empower clinicians to confidently integrate precision oncology into routine patient care.” said Lim Chiun Khee, Country Director, Gene Solutions Malaysia.

For patients and families, cancer genomics may appear complex, but its purpose is clear: to understand the disease more completely so that treatment decisions can become more precise.

Through the K-CONNECT Platform, K-CONNECT Summit and Precision Oncology Academy, Gene Solutions continues to connect scientific advancement with clinical practice, helping make the evolving possibilities of precision oncology more accessible to clinicians and, ultimately, more meaningful for patients.

About Gene Solutions

Gene Solutions is a global biotechnology company headquartered in Singapore with a mission to make advanced genomic solutions accessible and affordable. Leveraging next-generation sequencing, multi-omics and artificial intelligence, the company offers a portfolio of solutions across multi-cancer detection, precision oncology and reproductive health, including SPOT-MAS, K-TRACK and K-4CARE.

Gene Solutions operates CAP-accredited NGS laboratories and has delivered millions of genetic tests worldwide since 2017. For more information, visit www.genesolutions.com and follow Gene Solutions on LinkedIn, Facebook, and X (Twitter).

For inquiries, please contact pr@genesolutions.com

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/gene-solutions-advances-precision-oncology-education-in-malaysia-with-the-beyond-actionable-academy-302841040.html

SOURCE Gene Solutions; GENE SOLUTIONS SGP PTE. LTD.

Related Topics:
Continue Reading

Technology

SparkLabs and Mirae Asset Launch a Venture Capital Fund for Central Asian Startups

Published

2 hours ago

on

September 20, 2026

By

SEOUL, South Korea, Sept. 20, 2026 /PRNewswire/ — Qazaqstan Investment Corporation (QIC), IT Park Ventures (Uzbekistan), Mirae Asset Venture Investment and SparkLabs Group have signed a term sheet to establish SparkLabs Mirae Silk Road Fund I LP, a new venture capital fund. The fund will be managed by Mirae Asset Venture Investment and SparkLabs Group.

The signing took place in Seoul during the state visits of the Presidents of Kazakhstan and Uzbekistan to Korea and the first Central Asia–Republic of Korea Summit.

During this past week, South Korea and Kazakhstan signed commercial agreements worth US$18.95 billion. Kazakhstan is a country of 20 million people with its core industries being oil and gas, and among the highest producers of iron and silver in the world. Uzbekistan is a country of 39 million people, and they are the largest electricity producer in Central Asia.

Qazaqstan Investment Corporation (QIC) is Kazakhstan’s national fund of funds and are anchor investors along with IT Park Ventures, the venture capital arm of the country’s state technology park. The new venture capital fund will back Central Asian startups at the Series A and later, which are businesses with a proven model that are ready to scale beyond the region. The fund is sector-agnostic but focuses on AI-native companies, where artificial intelligence is core to the product and business model.

“Higgsfield becoming Kazakhstan’s first unicorn was a turning point. It showed that a world-class AI company can be built in Central Asia. And it won’t be the last with more than half of the region’s population is under 30, growing up digital and our governments actively investing in AI. Yet the region is still largely overlooked by international investors, and that’s the opportunity this fund is built for,” explained Aslan Sultanov, Co-founder and General Partner at SparkLabs Mirae Silk Road.

Former Coinbase CTO and Partner at Andreessen Horowitz, Balaji Srinivasan, reopened his Network School in Kazakhstan last month. Telegram launched an AI lab and opened their first regional office in Kazakhstan this past year.

Beyond capital, portfolio companies will gain access to the SparkLabs and Mirae Asset’s global networks, along with hands-on support in expanding into South Korea, the United States and the MENA region.

About the Partners

SparkLabs Group is a network of startup accelerators and venture capital funds that has invested in over 600 startups across 6 continents since December 2013. These companies include OpenAI, SpaceX, Vectara, Kneron, Anthropic, Nex Team, Kraken, GenG, Lyft, MetAI, and others.

Mirae Asset Venture Investment is the venture capital arm of Mirae Asset Financial Group, one of Asia’s largest independent financial groups with over US$845 billion in assets under management. The company operates worldwide across 18 markets, and manages a fully diversified global investment platform encompassing ETFs, alternative investments, and traditional strategies.

Qazaqstan Investment Corporation (QIC) is Kazakhstan’s national fund of funds and part of Baiterek National Managing Holding. QIC invests in private equity and venture capital funds alongside international and private partners, with the goal of attracting long-term capital into Kazakhstan and developing the country’s investment ecosystem. QIC participates in 19 funds with a combined capitalization of $2.8 billion.

IT Park Ventures is the venture capital arm of IT Park Uzbekistan, the country’s state technology park and the main platform supporting Uzbekistan’s IT industry and tech exports. IT Park Ventures invests in startups from Uzbekistan and Central Asia and co-invests with international funds, connecting regional founders with global capital and markets.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sparklabs-and-mirae-asset-launch-a-venture-capital-fund-for-central-asian-startups-302883810.html

SOURCE SparkLabs Group

Continue Reading

Technology

AECOM Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Hackers Allege Theft of More Than 1 TB of Data

Published

3 hours ago

on

September 20, 2026

By

National class action law firm offers free, confidential case evaluations to AECOM employees, clients, and others whose personal information may have been exposed in the reported AECOM data breach.

DALLAS, Sept. 20, 2026 /PRNewswire/ — Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from a reported data breach at AECOM, the U.S.-based multinational infrastructure and engineering firm. Anyone who has received a data breach notice from AECOM, or who believes their personal information may have been exposed, can request a free case evaluation.

AECOM data breach — at a glance:

Company: AECOM, a Texas-based, multibillion-dollar multinational infrastructure consulting, engineering, design, and construction management firm.Reported: A cyberattack said to have occurred on or about September 17, 2026, first surfaced on dark web monitoring sites.Hackers’ claims: The group Metaencryptor claimed responsibility for an attack said to involve approximately 1.22 terabytes (TB) of data. Separately, dark web monitoring service Breachsense listed a related AECOM leak of roughly 670GB attributed to a group identified as BrainCipher.Status: The breach and the hackers’ claims remain unconfirmed. AECOM has not publicly detailed the scope or impact.Who may be affected: Current and former AECOM employees, clients, and others whose data AECOM held.Cost to you: Nothing. Case evaluations are free and confidential.

What Happened

According to a September 17, 2026 post on the dark web monitoring site Ransomware.live, the hacker group Metaencryptor claimed responsibility for a cyberattack on AECOM that allegedly affected about 1.22 TB of data. The cybersecurity blog HookPhish similarly reported that Metaencryptor was behind a suspected attack on the engineering firm.

Separately, the dark web monitoring service Breachsense reported an AECOM data leak listed at approximately 670GB, attributed to a group it identified as BrainCipher. Breachsense also indexed thousands of AECOM-linked credentials circulating online, including 27,434 @aecom.com accounts drawn from external breaches and 6,077 credentials tied to aecom.com itself — among them thousands of logins found in “combo lists” and in infostealer malware logs, many with plaintext passwords. Breachsense cautioned that those credentials may belong to either customers or staff and are not necessarily connected to the claimed attack.

The breach has not been confirmed, and important details (including its true scope, the specific data involved, and the number of people affected) are not yet publicly available.

What Personal Information May Be at Risk

The specific data involved in the reported AECOM data breach has not been confirmed. Data breaches like this can expose personal information, increasing the risk of identity theft and fraud. Affected individuals should treat any AECOM breach notification seriously.

Who May Be Affected by the AECOM Data Breach

The investigation focuses on current and former AECOM employees, clients, and anyone else whose personal information AECOM maintained. Anyone who has received a data breach notification from AECOM may face an increased risk of identity theft and fraud and is encouraged to come forward.

Your Legal Options

Edelson Lechtzin LLP is investigating a potential class action to pursue legal remedies on behalf of individuals whose sensitive personal data may have been compromised in the reported AECOM breach. A successful case could recover compensation for losses such as lost time, out-of-pocket costs, and loss of privacy, and could push AECOM to strengthen how it protects personal information. The firm will evaluate your rights and potential claims at no cost.

Recommended Steps to Protect Yourself

Review your account statements and credit reports regularly and stay alert for suspicious activity.Confirm whether your information was involved in the AECOM incident.Preserve any letters or emails you received about the breach.Consider placing fraud alerts and enrolling in credit monitoring.

Contact Us for a Free Case Evaluation

Speak confidentially with a data privacy attorney today: Marc Edelson, Esq., Edelson Lechtzin LLP, 411 S. State Street, Suite N-300, Newtown, PA 18940; Phone: 844-696-7492; Email: medelson@edelson-law.com; Web: www.edelson-law.com. Or click HERE to request a free consultation.

About Edelson Lechtzin LLP

Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to data breach litigation, the firm handles class and collective actions involving securities and investment fraud, federal antitrust violations, ERISA employee benefit plans, wage theft, and consumer fraud.

Media and Partnership Inquiries: Use the contact information above to connect with our team regarding interviews, co-counsel opportunities, and referral partnerships.

Legal Notice: This press release may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee a similar outcome. The reported data breach and the hackers’ claims described above are unconfirmed.

View original content to download multimedia:https://www.prnewswire.com/news-releases/aecom-data-breach-investigation-edelson-lechtzin-llp-probes-class-action-claims-after-hackers-allege-theft-of-more-than-1-tb-of-data-302884076.html

SOURCE Edelson Lechtzin LLP

Continue Reading

Technology

iScreen Reaches No. 1 in Graphics & Design Across 94 Markets Following iOS 27 Update

Published

6 hours ago

on

September 20, 2026

By

Extra-large widget experiences, iOS 27-inspired themes and new customization tools drive iScreen’s latest global growth

LOS ANGELES, Sept. 20, 2026 /PRNewswire/ — iScreen, a mobile customization app for iOS and Android, announced that it has reached No. 1 in the Graphics & Design category across 94 countries and regions following its latest iOS 27-focused update.

The update expands iScreen’s Home Screen customization experience with new extra-large widgets, iOS 27-inspired themes, layouts optimized for new screen proportions, and AI-assisted design tools.

Extra-Large Widgets

Built for the larger widget canvas available in iOS 27, iScreen’s new extra-large widgets go beyond simply scaling up existing formats. The collection includes Photo, Album, Music, Calendar, Interactive Refrigerator and Quick Launch widgets, among others. Users can also customize content, layouts and visual styles to create more functional and expressive Home Screen experiences.

iOS 27-Inspired Themes and iPhone Duo Theme Support

iScreen has introduced new iOS 27-inspired themes that combine coordinated wallpapers, transparent-style widgets, icons and other visual elements into complete Home Screen setups.

Selected themes have also been optimized for iPhone Duo’s screen proportions and display dimensions, with wallpapers, widgets and icons adjusted to better fit the new format while maintaining a cohesive visual experience.

AI-Assisted Home Screen Design

iScreen is also testing AI Home Screen Designer with a limited group of users. The feature generates coordinated design suggestions based on users’ preferences for style, color and visual elements, combining wallpapers, widgets and icons into a unified setup.

“The latest iOS update has opened up new possibilities for mobile personalization,” said the iScreen team. “We want to turn those capabilities into practical and creative experiences that make Home Screen design easier and more expressive.”

About iScreen

iScreen is a mobile customization app offering widgets, wallpapers, themes and Home Screen customization tools for iOS and Android devices. With more than 100 million users worldwide, iScreen has ranked No. 1 in Graphics & Design across 94 countries and regions and has been featured by Apple Editorial in 128 countries for five consecutive days.

Official Website: iScreen – Phone Style, iScreen it!
iOS Download: ‎‎iScreen – Widgets & Wallpaper App – App Store
Android Download: iScreen Google Play

View original content:https://www.prnewswire.co.uk/news-releases/iscreen-reaches-no-1-in-graphics–design-across-94-markets-following-ios-27-update-302883972.html

Continue Reading

Trending